Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Clinical Oncology

• Publication date

  2014-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2014.56.1068PMID 25135988PMCID PMC4171356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hormonal Carcinogenesis

  2020cited by this paper
• Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study

  2014cited by this paper
• Validation of Rosner–Colditz breast cancer incidence model using an independent data set, the California Teachers Study

  2013cited by this paper
• Challenges to the measurement of estradiol: an endocrine society position statement.

  2013cited by this paper
• A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development.

  2013cited by this paper
• Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study

  2013cited by this paper
• Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up

  2013cited by this paper
• A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance

  2012cited by this paper
• The Heritability of Mammographic Breast Density and Circulating Sex-Hormone Levels: Two Independent Breast Cancer Risk Factors

  2012cited by this paper
• Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement

  2012cited by this paper
• Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status

  2012cited by this paper
• Age at menopause: imputing age at menopause for women with a hysterectomy with application to risk of postmenopausal breast cancer.

  2011cited by this paper
• Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor‐positive breast cancer in Japanese women

  2011cited by this paper
• The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study

  2011cited by this paper
• Circulating Steroid Hormone Levels and Risk of Breast Cancer for Postmenopausal Women

  2010cited by this paper
• Performance of common genetic variants in breast-cancer risk models.

  2010cited by this paper
• Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information

  2010cited by this paper
• Physical activity and risk of breast cancer among postmenopausal women.

  2010cited by this paper
• Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion

  2010cited by this paper
• Toward excellence in testosterone testing: a consensus statement.

  2010cited by this paper
• Body fatness at young ages and risk of breast cancer throughout life.

  2010cited by this paper
• Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model.

  2009cited by this paper
• Power and Sample Size Estimation for the Wilcoxon Rank Sum Test with Application to Comparisons of C Statistics from Alternative Prediction Models

  2009cited by this paper
• Polygenes, risk prediction, and targeted prevention of breast cancer.

  2008cited by this paper
• Polygenes, risk prediction, and targeted prevention of breast cancer.

  2008cited by this paper
• Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study

  2008cited by this paper
• Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model

  2008cited by this paper
• Determination of blood pressure percentiles in normal-weight children: some methodological issues.

  2008cited by this paper
• Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.

  2007cited by this paper
• Prolactin and breast cancer risk.

  2006cited by this paper
• Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.

  2006cited by this paper
• Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

  2005cited by this paper
• Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.

  2005cited by this paper
• Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.

  2004cited by this paper
• Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study

  2004cited by this paper
• Plasma Prolactin Concentrations and Risk of Postmenopausal Breast Cancer

  2004cited by this paper
• Breast cancer risk prediction with a log-incidence model: evaluation of accuracy.

  2003cited by this paper
• The role of prolactin in mammary carcinoma.

  2003cited by this paper
• Roles of androgens in the development, growth, and carcinogenesis of the mammary gland.

  2002cited by this paper
• Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

  2002cited by this paper
• Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

  2001cited by this paper
• Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

  2001cited by this paper
• Hormonal carcinogenesis.

  2000cited by this paper
• Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

  2000cited by this paper
• Induction of high incidence of mammary tumour in female Noble rats with a combination of 17beta-oestradiol and testosterone.

  1999cited by this paper
• Validation studies for models projecting the risk of invasive and total breast cancer incidence.

  1999cited by this paper
• Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors.

  1998cited by this paper
• Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women.

  1995cited by this paper
• Prolactin and breast cancer risk

  1990cited by this paper
• Estimation of Average Concentration in the Presence of Nondetectable Values

  1990cited by this paper
• Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

  1989cited by this paper
• Meta-analysis in clinical trials.

  1986influential reference
• Percentage Points for a Generalized ESD Many-Outlier Procedure

  1983cited by this paper
• Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosis.

  1979cited by this paper
• Practice of Epidemiology Adjusting for Covariates in Studies of Diagnostic, Screening, or Prognostic Markers: an Old Concept in a New Setting

  year unknowncited by this paper
• Performance of Common Genetic Variants in Breast-cancer Risk Models

  year unknowncited by this paper

• Development and performance of female breast cancer incidence risk prediction models: a systematic review and meta-analysis

  2025cites this paper
• Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms

  2024cites this paper
• Male breast cancer differs from female breast cancer in molecular features that affect prognoses and drug responses

  2024cites this paper
• The risk of breast cancer and gynecologic malignancies after ovarian stimulation: meta-analysis of cohort study.

  2024cites this paper
• Breast cancer histopathology, classification and clinical management: Current perspectives

  2024cites this paper
• Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers

  2023cites this paper
• Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis

  2023cites this paper
• Application of Metabolomics to Epidemiologic Studies of Breast Cancer: New Perspectives for Etiology and Prevention

  2023cites this paper
• Associations of gut microbiome with endogenous estrogen levels in healthy postmenopausal women

  2023cites this paper
• Predictive model of risk and severity of enteritis in systemic lupus erythematosus

  2022cites this paper
• Prolactin: The Third Hormone in Breast Cancer

  2022cites this paper
• Estrogenic activity and risk of invasive breast cancer among postmenopausal women in the Nurses' Health Study.

  2022cites this paper
• Linking Physical Activity to Breast Cancer via Sex Steroid Hormones, Part 2: The Effect of Sex Steroid Hormones on Breast Cancer Risk

  2021cites this paper
• NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers

  2021cites this paper
• Prolactin and Risk of Epithelial Ovarian Cancer

  2021influential citation
• The prediction of asymptomatic carotid atherosclerosis with electronic health records: a comparative study of six machine learning models

  2021cites this paper
• Weight Regain and Breast Cancer–Related Biomarkers Following an Exercise Intervention in Postmenopausal Women

  2021cites this paper
• Prolactin: A hormone with diverse functions from mammary gland development to cancer metastasis.

  2020cites this paper
• Of Cancer Risk Prediction Models

  2020cites this paper
• Sedentary behavior and risk of breast cancer: a dose–response meta-analysis from prospective studies

  2020cites this paper
• The Steroid Metabolome and Breast Cancer Risk in Women with a Family History of Breast Cancer: The Novel Role of Adrenal Androgens and Glucocorticoids

  2020cites this paper
• Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer

  2020cites this paper
• A Comprehensive Evaluation Of Breast Cancer Risk Prediction Using Uk Biobank Data

  2020cites this paper
• Workshop on normal reference ranges for estradiol in postmenopausal women, September 2019, Chicago, Illinois.

  2020cites this paper
• Combination of phenotype and polygenic risk score in breast cancer risk evaluation in the Spanish population: a case –control study

  2020cites this paper
• Predicting Circulating CA125 Levels among Healthy Premenopausal Women

  2019cites this paper
• Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model

  2019cites this paper
• Deep Learning Model to Assess Cancer Risk on the Basis of a Breast MR Image Alone.

  2019cites this paper
• The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.

  2019cites this paper
• Breast Cancer Prevention

  2019cites this paper
• Comparison of Questionnaire-Based Breast Cancer Prediction Models in the Nurses' Health Study

  2019cites this paper
• Prediction of fetal loss in Chinese pregnant patients with systemic lupus erythematosus: a retrospective cohort study

  2019influential citation
• Estimating the receiver operating characteristic curve in matched case control studies

  2018cites this paper
• Towards Prevention of Breast Cancer: What Are the Clinical Challenges?

  2018cites this paper
• Predicting high-risk endometrioid carcinomas using proteins

  2018cites this paper
• Measuring estrogens in women, men, and children: Recent advances 2012-2017.

  2018cites this paper
• Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case–control study

  2018cites this paper
• Inclusion of Plasma Prolactin Levels in Current Risk Prediction Models of Premenopausal and Postmenopausal Breast Cancer

  2018cites this paper
• Explorer Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States

  2018cites this paper
• Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications

  2017cites this paper
• Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort

  2017influential citation
• Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones

  2017influential citation
• Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre- and postmenopausal Japanese women

  2017cites this paper
• Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk

  2017cites this paper
• Breast cancer risk prediction: an update to the Rosner–Colditz breast cancer incidence model

  2017cites this paper
• Determinants of prolactin in postmenopausal Chinese women in Singapore

  2017cites this paper
• Endogenous sex hormones and cognitive function in older women

  2016cites this paper
• Linseed as a functional food for the management of obesity

  2016cites this paper
• Lack of Association between CYP 1 A 1 M 2 and M 4 Polymorphisms and Breast Carcinoma in Jordanian Women : a Case-Control Study

  2016cites this paper
• Lack of Association between CYP1A1 M2 and M4 Polymorphisms and Breast Carcinoma in Jordanian Women:

  2016cites this paper
• Lack of Association between CYP1A1 M2 and M4 Polymorphisms and Breast Carcinoma in Jordanian Women: a Case-Control Study.

  2016cites this paper
• Incorporating Biomarkers in Studies of Chemoprevention.

  2016cites this paper
• The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases

  2016cites this paper
• Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.

  2016cites this paper
• Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.

  2016cites this paper
• Update on breast cancer risk prediction and prevention

  2015cites this paper
• Effects of a High vs Moderate Volume of Aerobic Exercise on Adiposity Outcomes in Postmenopausal Women: A Randomized Clinical Trial.

  2015cites this paper
• Effects of exercise dose on endogenous estrogens in postmenopausal women: a randomized trial.

  2015cites this paper
• HORMONAL IMPACT ON TUMOR GROWTH AND PROGRESSION

  2015cites this paper
• Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.

  2015cites this paper
• Risk Prediction Models: Applications in Cancer Prevention

  2015cites this paper
• Mechanisms and Risk Factors of Cognitive Aging

  2015cites this paper
• The Relationship Between Bilateral Oophorectomy and Plasma Hormone Levels in Postmenopausal Women

  2015cites this paper
• Hormonal impact on tumor growth and progression.

  2015cites this paper
• Risk determination and prevention of breast cancer

  2014cites this paper
• Breast Cancer Prevention

  2014cites this paper
• Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women

  2014cites this paper